Wilson Mark Andrew

Chief Legal Officer | SVP &General Counsel

1 company

Good

Trades Analyzed

12M Win Rate

50.0%

Avg 3M Return

-3.7%

Avg 12M Return

-3.4%

Wilson Mark Andrew is a Chief Legal Officer at NEKTAR THERAPEUTICS. Recent SEC Form 4 filings include 0 buys and 11 sells.

Estimated insider holdings value: $1.8M based on current market prices.

Holdings by Company

NKTRNov 25, 2025

Current Shares21.6K

Value$1.77M

Net Activity-169,627

Bought: 0Sold: 169.6K

Showing 10 filings

Date	Ticker	Role	Type	Shares	Price	Value	Chg%	3M	12M
Nov 25, 2025	NKTR Nektar Therapeutics	Chief Legal Officer	Sell	630	$54.28	$34,196.40	-2.8%	+21.9%	-
Aug 19, 2025	NKTR Nektar Therapeutics	Chief Legal Officer	Sell	676	$26.59	$17,974.84	-3.2%	+123.0%	-
May 19, 2025	NKTR Nektar Therapeutics	Chief Legal Officer	Sell	9,996	$0.67	$6,697.32	-3.1%	+163.1%	-
Feb 19, 2025	NKTR Nektar Therapeutics	Chief Legal Officer	Sell	11,040	$1.01	$11,150.40	-3.3%	-31.3%	+392.4%
Dec 24, 2024	NKTR Nektar Therapeutics	Chief Legal Officer	Sell	49,962	$0.90	$44,800.20	-6.8%	-5.2%	+222.7%
Nov 19, 2024	NKTR Nektar Therapeutics	Chief Legal Officer	Sell	6,407	$1.01	$6,471.07	-2.8%	+2.9%	+290.6%
Aug 19, 2024	NKTR Nektar Therapeutics	Chief Legal Officer	Sell	5,651	$1.28	$7,233.28	-2.4%	-22.6%	+33.9%
May 17, 2024	NKTR Nektar Therapeutics	Chief Legal Officer	Sell	6,260	$1.75	$10,955.00	-2.6%	-32.2%	-61.0%
Feb 20, 2024	NKTR Nektar Therapeutics	Chief Legal Officer	Sell	7,606	$0.68	$5,172.08	-3.1%	+163.7%	+50.7%
Nov 17, 2023	NKTR Nektar Therapeutics	Chief Legal Officer	Sell	7,179	$0.49	$3,517.71	-2.9%	+53.7%	+122.2%